PURPOSE: We report on the results of the whole-genome analysis performed in a patient who developed severe ovarian hyperstimulation syndrome (OHSS) following gonadotropin-releasing hormone (GnRH) agonist triggering in a "freeze-all" protocol. METHODS: A 30-year-old patient with polycystic ovary syndrome who developed severe early-onset OHSS with clinical ascites, and slight renal and hepatic dysfunction was admitted for monitoring and treatment with cabergoline and intravenous albumin. Exome sequencing to assess for any known genetic predisposition for OHSS was performed. RESULTS: No known genetic variants associated with OHSS predisposition were found. CONCLUSIONS: Case reports of severe OHSS following a "freeze-all" strategy are starting to arise, showing that OHSS has not been completely eliminated with this approach. Further studies should be conducted to confirm if such cases may be due to genetic predisposition or not.
PURPOSE: We report on the results of the whole-genome analysis performed in a patient who developed severe ovarian hyperstimulation syndrome (OHSS) following gonadotropin-releasing hormone (GnRH) agonist triggering in a "freeze-all" protocol. METHODS: A 30-year-old patient with polycystic ovary syndrome who developed severe early-onset OHSS with clinical ascites, and slight renal and hepatic dysfunction was admitted for monitoring and treatment with cabergoline and intravenous albumin. Exome sequencing to assess for any known genetic predisposition for OHSS was performed. RESULTS: No known genetic variants associated with OHSS predisposition were found. CONCLUSIONS: Case reports of severe OHSS following a "freeze-all" strategy are starting to arise, showing that OHSS has not been completely eliminated with this approach. Further studies should be conducted to confirm if such cases may be due to genetic predisposition or not.
Authors: S T Sherry; M H Ward; M Kholodov; J Baker; L Phan; E M Smigielski; K Sirotkin Journal: Nucleic Acids Res Date: 2001-01-01 Impact factor: 16.971
Authors: Francisco J Morón; Francisco de Castro; Jose L Royo; Luis Montoro; Emilia Mira; María E Sáez; Luis M Real; Alejandro González; Santos Mañes; Agustín Ruiz Journal: Pharmacogenet Genomics Date: 2006-07 Impact factor: 2.089
Authors: Human Mousavi Fatemi; Biljana Popovic-Todorovic; Peter Humaidan; Shahar Kol; Manish Banker; Paul Devroey; Juan Antonio García-Velasco Journal: Fertil Steril Date: 2014-02-15 Impact factor: 7.329
Authors: Travis J O'Brien; Mariah M Kalmin; Arthur F Harralson; Adam M Clark; Ian Gindoff; Samuel J Simmens; David Frankfurter; Paul Gindoff Journal: Reprod Biol Endocrinol Date: 2013-07-25 Impact factor: 5.211
Authors: Katrien Stouffs; Sari Daelemans; Samuel Santos-Ribeiro; Sara Seneca; Alexander Gheldof; Ali Sami Gürbüz; Michel De Vos; Herman Tournaye; Christophe Blockeel Journal: J Assist Reprod Genet Date: 2018-11-27 Impact factor: 3.412
Authors: A Abbara; R Islam; S A Clarke; L Jeffers; G Christopoulos; A N Comninos; R Salim; S A Lavery; T N L Vuong; P Humaidan; T W Kelsey; G H Trew; W S Dhillo Journal: Clin Endocrinol (Oxf) Date: 2018-03-06 Impact factor: 3.478